Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease

Tarsus Pharmaceuticals has dosed the first participant in its Phase 2 Calliope trial evaluating TP-05 (lotilaner), an investigational oral systemic therapy aimed at preventing Lyme disease by killing infected ticks before transmission. The randomized, placebo-controlled trial will enroll approximately 700 adults at risk across endemic U.S. regions,…

BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

BIO-key Reports 2025 Results and Substantially Improved Cash Position, Supporting Expected Strong Growth in 2026; Investor Call Today at 10am ET

BIO-key International announced its 2025 financial results showing $6.1M revenue with a 12% decline from 2024 due to strategic shifts in the EMEA region. The company improved its cash position to $2.7M and expects solid revenue growth and improved profitability in 2026, driven by increased demand in foreign military, defense, financial sectors, and…

PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA

PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA

PolyPid Ltd. has begun submitting its New Drug Application for D-PLEX100 to the FDA under a rolling review process, targeting approval by Q2 2026. The lead product, designed to prevent surgical site infections after colorectal surgery, demonstrated significant efficacy in Phase 3 trials and has received FDA Breakthrough Therapy Designation. The com…

GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results

GoHealth Prioritizes Consumer Fit, Renewal Economics and Cash Discipline While Continuing Leadership in Special Needs Plans; Reports Full Year 2025 Results

GoHealth, Inc. announced its full year 2025 financial results, emphasizing a strategic pullback in Medicare Advantage enrollments due to market conditions. The company prioritized consumer fit, renewal economics, cash discipline, and continued leadership in specialized needs plans (SNPs). GoHealth invested in AI and technology to improve efficiency…

BlockchAIn Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Following Public Listing

BlockchAIn Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Following Public Listing

BlockchAIn Digital Infrastructure, Inc. (NYSE American: AIB) completed its business combination and began public trading in March 2026. The company operates a 40 MW data center and is advancing its growth plans with over $500 million in potential contract value from letters of intent. BlockchAIn focuses on AI and HPC digital infrastructure developm…

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Nuwellis, Inc. announced that its pediatric category has become its largest and fastest-growing revenue segment, comprising approximately 50% of total U.S. revenue in 2025. The Aquadex therapy platform's adoption has expanded to 47 pediatric centers, including six of the top 10 children's hospitals, reflecting strong clinical acceptance and strateg…

Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering to Refinance Former Project Financing and to Fund Partial Buyback of Existing Gold Stream

Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering to Refinance Former Project Financing and to Fund Partial Buyback of Existing Gold Stream

Skeena Resources Limited announces a proposed $750 million offering of Senior Secured Notes due 2031 to refinance former project financing and fund a partial buyback of its existing $200 million gold stream. The transaction aims to improve operating margins, increase exposure to gold prices, and enhance project economics for the Eskay Creek Gold-Si…

Edible Garden Reports 2025 Results — Accelerates Planned Expansion into Higher-Margin Ready-to-Drink (RTD) and Shelf-Stable CPG Platform

Edible Garden Reports 2025 Results — Accelerates Planned Expansion into Higher-Margin Ready-to-Drink (RTD) and Shelf-Stable CPG Platform

Edible Garden AG Incorporated reported its 2025 financial results, highlighting strategic expansion beyond controlled environment agriculture into higher-margin ready-to-drink (RTD) and shelf-stable consumer packaged goods. The company increased its retail footprint to nearly 6,000 locations, including major partners like Kroger and Amazon, and is …

Kartoon Studios Provides Business Update

Kartoon Studios Provides Business Update

Kartoon Studios announced a 21% increase in total revenue to $39.4 million for 2025, driven largely by a 50% growth in animation production services. The company's operating loss improved by 24%, reflecting cost discipline and a shift toward higher-margin franchise monetization. Kartoon Studios is scaling its distribution platforms with record subs…

Foremost Clean Energy Closes Bought Deal Private Placement for Aggregate Gross Proceeds of C$5.7 Million

Foremost Clean Energy Closes Bought Deal Private Placement for Aggregate Gross Proceeds of C$5.7 Million

Foremost Clean Energy Ltd. completed a bought deal private placement raising aggregate gross proceeds of C$5.7 million by issuing flow-through units to support exploration of its uranium and lithium properties in Canada. The capital will be used to incur qualifying Canadian exploration expenses on the company's mineral properties in Saskatchewan an…

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting

Cadrenal Therapeutics reported strong fourth quarter and full-year 2025 results, highlighted by positive Phase 2 clinical data for its lead drug CAD-1005 treating heparin-induced thrombocytopenia (HIT). The company completed an End-of-Phase 2 meeting with the FDA, clarifying the regulatory strategy for its Phase 3 pivotal trial. CAD-1005 showed a s…

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Pelthos Therapeutics announced the dosing of the first patient in a Phase 1b/2a clinical trial evaluating CT2000, an investigational NaV1.7 inhibitor eye drop formulation, as a treatment for acute and chronic ocular pain associated with dry eye disease. The trial will assess safety and efficacy with results expected by the end of 2026. Positive pre…

Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth

Dycom Industries, Inc. Appoints Company Veteran Bo Gresham as its First Chief Revenue Officer to Lead Next Phase of Growth

Dycom Industries appoints industry veteran Bo Gresham as its first Chief Revenue Officer to lead revenue growth and strategic market expansion amid a multi-year boom in digital infrastructure and fiber deployments. With nearly 30 years of experience, Gresham's promotion reflects Dycom's commitment to internal talent development and positions the co…

Micron Announces the Pricing of the Cash Tender Offers for Any and All of Certain Outstanding Senior Notes

Micron Announces the Pricing of the Cash Tender Offers for Any and All of Certain Outstanding Senior Notes

Micron Technology announced the pricing and terms for cash tender offers to repurchase various series of its outstanding senior notes, totaling several billion dollars. The offers include specific reference yields and notes considerations, with an expiration date of March 31, 2026, and expected settlement on April 3, 2026. The company emphasizes th…

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

Indivior Pharmaceuticals released a new cost impact model showing that their extended-release monthly injectable buprenorphine, SUBLOCADE®, could significantly reduce staff time and related costs in jails and prisons compared to other opioid use disorder medications. The model suggests reduced staffing needs and operational costs, potentially enhan…

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform

Avalon GloboCare Corp., through its subsidiary Avalon Quantum AI LLC, has partnered with Caylent, an AWS Premier Tier Consulting Partner, to develop phase 2 of its Catch-Up AI video platform. The platform aims to evolve from a manually configured AI video system into a fully autonomous agentic AI video content creation and distribution solution tar…

Best Choice Roofing Surpasses One Billion Shingles Installed, Accelerates National Growth with ServiceTitan

Best Choice Roofing Surpasses One Billion Shingles Installed, Accelerates National Growth with ServiceTitan

ServiceTitan announced its ongoing technology partnership with Best Choice Roofing, which has surpassed one billion shingles installed. Best Choice Roofing is leveraging ServiceTitan's platform to standardize operations, enhance efficiency, and support nationwide expansion across over 80 locations. The partnership underpins Best Choice’s commitment…

SCYNEXIS Announces $40.0 Million Private Placement

SCYNEXIS Announces $40.0 Million Private Placement

SCYNEXIS, a biotechnology company developing therapies for severe rare diseases, announced a private placement expected to raise $40 million upfront, with the potential additional $52.2 million from warrant exercises pending shareholder approval. The proceeds are intended to fund general corporate purposes and extend operational runway into mid-202…

Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

Le Mans Ultimate Releases Version 1.3 Update, Introducing Circuit de Barcelona-Catalunya, Duqueine D09 LMP3 Race Car, New Track Layouts, Logitech Trueforce Support and Performance Improvements

Motorsport Games released version 1.3 update for Le Mans Ultimate featuring the final European Le Mans Series Season Pass pack including the Duqueine D09 LMP3 race car, Circuit de Barcelona-Catalunya, new track layouts, Logitech Trueforce and haptic feedback integration, and performance optimizations. The update enhances realism and gameplay experi…